During the past decade, Hospital Provincial de Castellon; Servicio de Oncologia conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 23 clinical trials were completed, i.e. on average, 37.1% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 15 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Provincial de Castellon; Servicio de Oncologia" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "Spanish Breast Cancer Research Group" with 8 trials sponsored, "MedSIR" with 7 trials sponsored, "Spanish Lung Cancer Group" with 6 trials sponsored and "Grupo Espanol Multidisciplinario del Cancer Digestivo" with 6 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Provincial de Castellon; Servicio de Oncologia" #1 collaborator was "Pfizer" with 5 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Novartis" with 3 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Provincial de Castellon; Servicio de Oncologia" are "Breast Cancer" (21 trials), "Non-Small Cell Lung Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Colorectal Cancer" (3 trials) and "Metastatic Breast Cancer" (3 trials). Many other conditions were trialed in "Hospital Provincial de Castellon; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital Provincial de Castellon; Servicio de Oncologia" are "Drug" (75 trials), "Other" (7 trials), "Radiation" (5 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (11 trials), "Atezolizumab" (7 trials), "Carboplatin" (7 trials), "Docetaxel" (7 trials) and "Placebo" (7 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Provincial de Castellon; Servicio de Oncologia" are 63 trials for "All" genders, 21 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Provincial de Castellon; Servicio de Oncologia". 1 are not yet recruiting, 15 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Hospital Provincial de Castellon; Servicio de Oncologia, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Provincial de Castellon; Servicio de Oncologia, 3 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 7 trials that are defined as “Not Applicable".